The bill will allow terminally ill patients to request experimental drugs that the FDA has not yet approved.
A bill that would speed up approval for medications and medical devices shows how a major initiative can get traction even in the midst of Washington gridlock—but critics say all the lobbying is drowning out some warnings about patient safety.
The new treatment may help overcome some courts‘ lingering—and dangerous—aversion to medication-assisted treatment.
The White House is considering eliminating the agency that coordinates America’s anti-drug strategy. Here’s what would happen next.
The calorie counts you’ve long seen at Starbucks will be at every chain restaurant starting today.
People with mental illnesses have a unique, intense relationship with smoking, which can ease distress as well as kill. Now that a much safer version of the habit is available, it’s no time for the anti-smoking lobby to play Nurse Ratched.
The DEA’s rule change allows other health-care professionals aside from just doctors to prescribe buprenorphine, an effective—but potentially addictive—treatment.
